Page 23 - IDEA Studie 07 2023 TACR

Large firms
526 -0.16 0.14 376 -0.08 0.35 290
IDEA 2023
r R&D expenditure (logs)
treatment . err.
0.27
0.41 0.36 0.35 0.36 0.49
0.21 0.27
During the treatment
After the treatment
N Coef. St. err. N Coef. St. err. N
526 -0.33** 0.15 376 -0.10 0.31 290
526 0.53*** 0.18 376 -0.26 0.46 290
526 0.86*** 0.24 376 -1.08 0.66 290
526 -0.24 0.16 376 -0.42* 0.22 290
526 0.12 0.43 376 0.46 0.7 290
526 -0.31** 0.12 376 -0.04 0.28 290
526 1.36*** 0.42 376 -0.80* 0.42 290
esults for SMEs and Columns 8–13 for large firms. The effects are estimated during (d) es include the pre-treatment logs of total R&D, R&D components by the source of funding r productivity, age, dummies for foreign ownership, shockholding, Prague location, and ar and call fixed effects as controls. Standard errors are clustered at the firm level. N is
21